Lu D P
Exp Hematol. 1981 Mar;9(3):257-63.
A patient with severe aplastic anaemia achieved restoration of marrow function following marrow transplantation from her identical twin. Sixteen years later both patient and donor are in good health without significant haematologic abnormality. This is the first case of successful syngeneic marrow transplantation reported in China. The success of this procedure, without immunosuppression, suggests that this patient's disease was due to a defect in haemopoietic stem cells rather than in marrow microenvironment. A review of the 23 other patients treated by syngeneic marrow transplantation for aplastic anaemia suggests that approximately one-half have a disease due primarily to a defect in stem cells. Conversely for a patient who does not recover haemopoiesis after syngeneic marrow transplantation a further transplant preceded by immunosuppressive therapy may be curative. No direct correlation between the number of syngeneic marrow cells transfused and the success of the graft can be discerned from the literature.
一名重症再生障碍性贫血患者在接受同卵双胞胎的骨髓移植后,骨髓功能得以恢复。16年后,患者和供者均健康良好,无明显血液学异常。这是中国报道的首例同基因骨髓移植成功案例。该手术在未进行免疫抑制的情况下取得成功,表明该患者的疾病是由于造血干细胞缺陷而非骨髓微环境缺陷所致。对其他23例接受同基因骨髓移植治疗再生障碍性贫血的患者进行回顾发现,约一半患者的疾病主要是由干细胞缺陷引起的。相反,对于同基因骨髓移植后未恢复造血功能的患者,在进行免疫抑制治疗后再次移植可能治愈。从文献中无法看出输注的同基因骨髓细胞数量与移植成功之间存在直接关联。